Mechanism of Action
At the molecular level, levothyroxine sodium acts as a prohormone. Upon entering the cell cytoplasm, thyroxine ($T_4$) undergoes conversion into triiodothyronine ($T_3$), which is 3–5 times more active than the parent compound.
The resulting $T_3$ enters the nucleus and stimulates intracellular receptors. This activates mRNA transcription and subsequently enhances protein synthesis. Thus, the drug interferes with basic cellular metabolism, mimicking the function of normal thyroid follicular elements where thyroglobulin iodination and iodotyrosine condensation normally take place.
Pharmacological Effects
The drug exerts systemic effects on the body, regulating metabolism and growth processes. Within the hypothalamic-pituitary axis, levothyroxine sodium participates in a negative feedback mechanism: elevated blood levels suppress the secretion of thyrotropin-releasing hormone (TRH) by the hypothalamus and thyroid-stimulating hormone (TSH) by the anterior pituitary.
Compared to pure $T_3$ preparations (liothyronine), levothyroxine acts more slowly and with lower potency, but offers an important clinical advantage: a lower arrhythmogenic potential.
Indications for Use
1. Replacement Therapy The primary goal is to compensate for hormone deficiency in endocrine hypofunction (hypothyroidism). Therapy does not correct the underlying etiology but alleviates deficiency symptoms. Administration is typically long-term, often lifelong.
2. Non-cardiac Indications
- Thyrotoxicosis: the drug exerts a pathogenetic effect by inhibiting the peripheral conversion of endogenous $T_4$ into the more active $T_3$.
- Neurology and Psychiatry:
- Migraine: prophylaxis of attacks by toning cerebral vessels and preventing painful pulsations.
- Essential tremor: reduction of tremors via blockade of skeletal muscle $\beta_2$-receptors.
- Anxiety disorders: alleviation of panic attacks and fear through central nervous system depression.
Adverse Effects and Risks
When prescribing the drug, its impact on various body systems must be considered:
- Lipid Profile: the drug exhibits atherogenic properties. This mechanism is associated with decreased endothelial lipoprotein lipase activity, leading to elevated triglycerides and VLDL, alongside a reduction in anti-atherogenic HDL.
- Reproductive Function: there is a risk of developing erectile dysfunction.
- Thyroid Hormone Metabolism: exogenous $T_4$ inhibits the peripheral conversion of endogenous thyroxine to triiodothyronine.
Administration and Prescription
The drug is administered orally, strictly in the morning 30 minutes before meals. Dosage is individualized (typically ranging from 0.000025 to 0.0001 g).
In clinical practice, levothyroxine sodium is frequently used in combination products, such as with potassium iodide (Iodothyrox) or in a triple combination with liothyronine and potassium iodide (Thyreocomb). Combinations of synthetic $T_4$ and $T_3$ (Thyreotom) are also available.
Prescription Example: ```latin Rp.: Tab. Levothyroxini natrii 0.0001 D.t.d. N. 50 S. Take orally 1 tablet in the morning 30 minutes before meals. ```